← All drugs

Drug companion protocol

Semaglutide (Ozempic)

Prescription only
GLP-1 receptor agonist

Also known as: Ozempic

A GLP-1 receptor agonist primarily indicated for type 2 diabetes management, also prescribed off-label for weight management.

Quickstart Highlights

Drug class
GLP-1 receptor agonist
Route
Subcutaneous injection
Schedule
Weekly subcutaneous injection
Evidence score
90

Quickstart highlights

  • šŸ’‰Subcutaneous injection
  • šŸ”¬GLP-1 receptor agonist
  • šŸ–ŠļøPre-filled autoinjector pen
  • šŸ“‹Prescription required

How this works

Mechanism of action and pharmacokinetic profile from published data.

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist. It mimics the gut hormone GLP-1 to increase glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite. In Ozempic, doses of 0.5–2 mg once weekly are used primarily to improve glycaemic control in type 2 diabetes. The glucose-dependent insulin effect means the risk of hypoglycaemia is low when semaglutide is used without other glucose-lowering agents.

Time to peak (Tmax)
24–72 hours after subcutaneous injection.
Clearance
Degraded via proteolytic and fatty acid oxidation pathways; renal dose adjustment is not required for mild-to-moderate impairment.
Elimination half-life
Approximately 1 week (7 days), supporting once-weekly dosing.
Bioavailability
High systemic absorption after subcutaneous injection; ~89% albumin-bound, which extends the half-life.

Injection guide

Supplies, step-by-step technique, safety notes, and AU sharps disposal.

Supplies needed

  • ā—¦Your prescribed Ozempic pen (correct strength) — Ozempic pens come in three strengths: 2 mg/1.5 mL (doses of 0.25 mg or 0.5 mg), 4 mg/3 mL (doses of 1 mg), and 8 mg/3 mL (doses of 2 mg). Confirm the pen strength matches your prescribed dose.
  • ā—¦A new pen needle — NovoFine or equivalent, typically 4 mm Ɨ 32G. Always use a new needle for each injection.
  • ā—¦Alcohol swab
  • ā—¦Sharps disposal container

Step-by-step

  1. 1Wash your hands thoroughly
  2. 2Remove pen from fridge 30 minutes before use

    Injecting room-temperature medicine is more comfortable and aids absorption.

  3. 3Check the pen and liquid

    The solution should be clear and colourless. Check the expiry date. Never use a cloudy or discoloured pen.

  4. 4Attach a new needle and prime if it is a new pen

    Attach the needle as described in the IFU. If this is a new pen or the first use after a break, do a flow check (prime): dial to the flow check symbol, point the pen upward, and press the button until a drop appears at the needle tip.

  5. 5Dial your prescribed dose

    Turn the dose selector until the prescribed dose appears in the dose window. If you dial past your dose, you can turn back.

  6. 6Choose and clean your injection site

    Abdomen (5 cm from navel), upper thigh, or upper arm. Wipe with an alcohol swab and let dry.

  7. 7Inject

    Hold the pen at 90° to the skin. Press firmly and press the injection button all the way. Hold for 6 seconds until the dose counter returns to 0.

  8. 8Remove needle and dispose immediately

    Recap using one-hand scoop, unscrew, drop directly into sharps container.

  9. 9Replace the pen cap and return to fridge

    The pen can be used until all doses are delivered or the expiry date, whichever comes first.

Important notes

  • !Never inject into a vein or muscle
  • !Never share your pen
  • !Rotate injection sites every week
  • !Do not inject into scar tissue, bruises, or broken skin
  • !If you miss a dose by more than 5 days, skip and resume on your regular day
  • !Tell all healthcare providers you are using Ozempic

    Gastric emptying is slowed — relevant for fasting before procedures and for absorption of oral medicines.

Sharps disposal

  • ā—¦Sharps container — do not place loose needles in household bins
  • ā—¦NestSafe mail-back (Australia) — free from participating pharmacies
  • ā—¦EnviroSafe mail-back (Australia) — available from pharmacies
  • ā—¦Community pharmacy drop-off — ask your dispensing pharmacy

Clinical Benefits & Side Effects

Observed outcomes, adverse effects, and lifecycle considerations from published trial data.

Benefits

Week 0

Starting Ozempic

Ozempic begins at 0.25 mg weekly for four weeks, then escalates to 0.5 mg. The starting dose is a tolerability step, not a therapeutic dose — blood sugar improvement and appetite change are more noticeable from 0.5 mg onward.

Week 1

First injection — taking the first step

You've taken your first dose, and that's a big deal. Most people feel little to nothing this week, though some notice mild nausea, a reduced appetite, or loose stools — especially in the day or two after the injection. Go gently, eat smaller meals, and don't expect dramatic changes just yet.

Week 2

Finding your injection routine

Your second injection is a chance to settle into a routine — same day, same time, same spot. Nausea, if it appeared last week, may still be present and can feel a little stronger for some people. Eating slowly and choosing plain, easy-to-digest foods can really help right now.

Week 3

Side effects may peak — stay the course

Weeks 2–4 are often the toughest for nausea and digestive discomfort, as your body is still adjusting to the medication. You might notice some fatigue or a reduced desire to eat large meals. This is normal — it doesn't mean the medication isn't working, it means your body is responding.

Week 4

One month in — body beginning to adjust

By the end of week four, many people notice the side effects beginning to ease a little. You're nearing the end of your starting dose phase, and your prescriber may soon discuss a dose increase. Don't be discouraged if the scale hasn't moved much — your body is doing a lot of internal adjusting.

Week 5

Dose may increase — appetite shifts ahead

If your prescriber has increased your dose, week five can feel like a reset — some of the nausea you thought had passed might return briefly. This is very common with dose escalation. On the positive side, appetite suppression often becomes noticeably stronger around this time.

Week 6

Appetite suppression becoming more noticeable

Many people report that food 'noise' — constant thoughts about eating — begins to quieten around this point. You may find yourself stopping mid-meal because you genuinely feel full. This is the medication working as intended, but be mindful to still eat enough nourishing food each day.

Week 7

Learning to listen to your hunger cues

With appetite suppression more consistent, this is a great week to practise tuning in to true hunger versus habit-based eating. Some people also notice cravings for sweet or fatty foods reducing. Digestive side effects for most people are more manageable now than in the early weeks.

Side effects

ā—¦Vomiting(mild)

Reported

ā—¦Diabetic retinopathy complications(moderate)

3.0% vs 1.8% placebo — rapid glucose improvement may unmask pre-existing changes; discuss with your ophthalmologist

ā—¦Diarrhoea(mild)

Common

ā—¦Injection-site reaction(mild)

Generally mild and transient

ā—¦Constipation(mild)

Reported

ā—¦Hypoglycaemia(mild-to-moderate)

Higher risk when combined with insulin or sulfonylureas

ā—¦Nausea(mild-to-moderate)

Common; most frequent during dose escalation

Lifecycle factors

Know the symptoms of low blood sugar if using other diabetes medicines

On its own, semaglutide rarely causes hypoglycaemia because its insulin-stimulating effect is glucose-dependent. However, if you are also using insulin or sulfonylureas, hypoglycaemia is a real risk. Know the signs: shakiness, sweating, confusion, rapid heartbeat.

Diabetic eye screening

Rapid improvement in blood sugar can occasionally cause transient worsening of diabetic eye changes. Attend your scheduled retinal screenings and let your ophthalmologist know you have started Ozempic.

Inform any medical or dental team

Delayed gastric emptying affects the timing and preparation for procedures requiring fasting or nil-by-mouth instructions. Tell every medical professional you see that you are on semaglutide.

Keep a symptom log to share with your prescriber

Tracking how you feel each week gives your prescriber genuinely useful information and helps them support you better. **Note down any side effects, their timing relative to your injection, and their severity** — even a simple 1–10 rating in your phone's notes app is helpful. This also helps you notice patterns, like realising nausea is worst on day two post-injection, which can inform when you choose to eat or plan activities.

Talk to your pharmacist — they're a great resource

Your pharmacist is an accessible and knowledgeable member of your care team, not just the person who hands you the medication. **They can answer questions about storage, injection technique, side effect management, and interactions with other medications**, often without needing an appointment. Don't hesitate to call or pop in between prescriber visits — that's exactly what they're there for.

Important note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. All information presented is based on published clinical trial data. Always follow your prescriber's instructions.

Nutrition & practical guidance

Food, hydration, and adherence tips compiled from trial data and clinical companion content.

Food and hydration

āœ… Prefer

Lean protein (chicken, fish, eggs, tofu, legumes)Low glycaemic index carbohydratesNon-starchy vegetables (leafy greens, zucchini, broccoli, cucumber)Lean protein at each mealWholegrains (rolled oats, brown rice, wholegrain bread)Non-starchy vegetablesPlain crackers, dry toast, or rice cakesLow-fat yoghurt and cottage cheeseRegular meal pattern

āš ļø Limit

High-fat foods (fried food, creamy sauces, pastries)High glycaemic foods (white bread, sugary drinks)Highly processed snack foods (chips, biscuits, fast food)

Adherence tips

administration

Rotate your injection sites consistently

Semaglutide is injected subcutaneously — into the fatty layer just under the skin — in the abdomen, outer thigh, or upper arm. **Rotate your injection site each week** to prevent skin irritation or lumps forming (lipohypertrophy). Keep a simple note on your phone or a sticky note on your pen to track where you injected last. Follow your prescriber's instructions on technique if you're unsure.

administration

Let your pen reach room temperature before injecting

Injecting cold medication straight from the fridge can increase discomfort and stinging at the injection site. **Take your pen out of the fridge 15–30 minutes before your injection** and let it come to room temperature. Store unused pens in the refrigerator (between 2°C and 8°C) and never freeze them.

administration

Inject on the same day each week

Keeping a consistent injection schedule prevents accidental double-dosing or long gaps. A gap of more than 14 days between doses requires restarting the escalation protocol — contact your prescriber if that happens.

timing

Choose a weekly injection day that works for your life

Pick a day of the week you can be consistent with — many people choose a day when they're home and relaxed, such as a Sunday morning. **Nausea tends to peak in the 24–48 hours after your injection**, so some people prefer to inject on a Friday night so the worst of it falls over the weekend. Set a phone reminder so you never have to think about whether you've done it.

nutrition

Prioritise protein at every meal

When your appetite is suppressed, it's easy to under-eat — and when you eat less, protein is the most important thing to prioritise to protect your muscle mass. **Aim for a palm-sized serving of protein** (chicken, fish, eggs, legumes, Greek yoghurt) at every meal. Even on days when nausea is limiting what you can eat, a small protein-rich snack like a boiled egg or some cottage cheese can help.

nutrition

Consistent carbohydrate distribution helps

Spreading carbohydrate intake evenly across meals, rather than loading at one meal, produces more stable glucose levels and can reduce post-meal nausea.

nutrition

Eat smaller meals more frequently

Semaglutide slows how quickly your stomach empties, which means large meals can sit heavily and trigger nausea or reflux. **Try eating 4–5 smaller meals or snacks across the day** rather than 2–3 large ones. Stop eating when you feel *comfortably* satisfied — not stuffed — and eat slowly to give your body time to signal fullness.

hydration

Sip water consistently throughout the day

Dehydration can make nausea significantly worse, and it's easy to forget to drink when you're not feeling hungry or thirsty. **Keep a 600 mL water bottle visible** on your desk or bench and aim to refill it at least three times a day. Sipping steadily is far more effective than trying to drink large amounts in one go, which can also trigger nausea.

hydration

Try ginger tea when nausea strikes

Ginger has well-supported properties for easing nausea and is a practical, low-effort option. **Brew a cup of ginger herbal tea or add a few thin slices of fresh ginger to hot water** after meals or when you're feeling unsettled. Peppermint tea is another good option if ginger isn't your preference. Avoid carbonated drinks when you're feeling nauseous, as they can worsen bloating.

mindset

Measure progress beyond the scale

The number on the scale is just one small part of the picture. **Keep a simple weekly journal** noting your energy levels, how your clothes feel, your mood, sleep quality, and how you're coping with meals. Many of the most meaningful early changes — reduced food cravings, steadier energy, better blood sugar patterns — won't show up on the scale at all. Celebrate those wins too.

mindset

Be patient with the early weeks — they are the hardest

Weeks one to four are genuinely difficult for many people, and it's completely normal to question whether it's worth it when you're feeling nauseous and not yet seeing results. **The side effects almost always ease significantly after the first month** as your body adjusts. If you're struggling, reach out to your prescriber — there are practical strategies that can help, and you don't have to just push through alone.

exercise

Start with gentle movement — walking is enough

You don't need to overhaul your exercise routine straight away. In the early weeks, **a 20–30 minute walk a few times a week** is genuinely enough to support your health and boost your mood. As nausea and fatigue ease (usually from weeks 5–8), you can gradually increase intensity. Pushing too hard too soon can worsen fatigue and make the adjustment period harder.

exercise

Add resistance training to protect muscle

When losing weight, the body can lose muscle alongside fat — resistance training is the most effective way to minimise this. **Aim for 2 sessions of resistance exercise per week**, even if it's just bodyweight exercises at home (squats, push-ups, lunges). If you're new to this, a single session with a qualified exercise physiologist can give you a safe, personalised starting point.

sleep

Protect your sleep — it supports everything else

Poor sleep increases hunger hormones (particularly ghrelin) and can work against the appetite-regulating effects of the medication. **Aim for 7–9 hours of quality sleep** by keeping a consistent bedtime, reducing screen exposure in the hour before bed, and keeping your bedroom cool and dark. If nausea is disrupting your sleep, try sleeping with your head slightly elevated.

administration

Dispose of used needles safely

Used sharps must be disposed of safely and responsibly — **never place them in household recycling or general rubbish bins**. In Australia, you can collect used needles in an approved sharps container and drop them off at your local pharmacy, council facility, or approved sharps disposal bin free of charge. Ask your pharmacist for a sharps container when you collect your prescription.

Safety and interactions

Share this information with your prescriber for personalised care decisions.

Who should not take this

Ozempic is a prescription medicine. Do not use if you have: • A personal or family history of medullary thyroid carcinoma (MTC) • Multiple endocrine neoplasia syndrome type 2 (MEN2) • A known allergy or hypersensitivity to semaglutide or any ingredient in the product Use with caution (discuss with your prescriber) if you have: • A history of pancreatitis • Diabetic retinopathy — discuss the risk of acute worsening during rapid glucose improvement • Severe kidney or liver disease • Active or recent eating disorder Not recommended during pregnancy or breastfeeding. Always disclose your full medical history to your prescriber.

Known interactions

  • Insulin and insulin secretagogues (e.g. sulfonylureas)
    significant

    Combination significantly increases hypoglycaemia risk. Prescribers typically reduce insulin or sulfonylurea doses when starting or escalating Ozempic.

  • Oral contraceptives
    moderate

    Gastric slowing may reduce the absorption of oral contraceptives, particularly around dose escalation. Discuss contraception options with your prescriber.

  • Medicines with narrow therapeutic index
    moderate

    Delayed gastric emptying may alter absorption of warfarin, some anti-epileptics, and ciclosporin. Additional monitoring may be warranted.

  • Alcohol
    moderate

    Increases nausea and the risk of hypoglycaemia when combined with insulin or sulfonylureas.

Storage and handling

Store the Ozempic pen in the refrigerator at 2–8°C (36–46°F) until first use. • After first use: keep below 30°C and use within 56 days (8 weeks). • Do not freeze — freezing damages the active molecule. • Keep the cap on between injections to protect from light. • Store away from children.

Research evidence

Published studies connected to this peptide with dosage and outcomes context.

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT)

Human trial Ā· 2023 Ā· New England Journal of Medicine Ā· n=17604 Ā· Adults with overweight or obesity, established cardiovascular disease, without type 2 diabetes at baseline

17,604 adults with established cardiovascular disease were randomised to semaglutide 2.4 mg weekly or placebo over ~33 months. Semaglutide reduced the risk of major adverse cardiovascular events (MACE — cardiovascular death, non-fatal MI, or non-fatal stroke) by 20% versus placebo (HR 0.80, 95% CI 0.72–0.90).

Reported outcomes

  • cardiovascular: 20% relative risk reduction in MACE versus placebo over ~33 months (SELECT trial — patients without diabetes). (Primary outcome)
DOI: 10.1056/NEJMoa2307563 ↗

Semaglutide versus Dulaglutide Once Weekly in Adults with Type 2 Diabetes (SUSTAIN 7)

Human trial Ā· 2018 Ā· The Lancet Diabetes & Endocrinology Ā· n=1201 Ā· Adults with type 2 diabetes uncontrolled on metformin

1,201 adults with type 2 diabetes on metformin were randomised to semaglutide 0.5 mg or 1 mg versus dulaglutide 0.75 mg or 1.5 mg weekly for 40 weeks. HbA1c reduction was significantly greater with semaglutide at matched doses, as was body-weight reduction. Adverse events were comparable.

DOI: 10.1016/S2213-8587(17)30423-X ↗

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6)

Human trial Ā· 2016 Ā· New England Journal of Medicine Ā· n=3297 Ā· Adults with type 2 diabetes and high cardiovascular risk

3,297 adults with type 2 diabetes and high cardiovascular risk were randomised to once-weekly subcutaneous semaglutide 0.5 mg or 1 mg, or placebo, for 104 weeks. MACE occurred in 6.6% of semaglutide participants versus 8.9% of placebo (HR 0.74, 95% CI 0.58–0.95), meeting the prespecified non-inferiority and superiority criteria.

Reported outcomes

  • hba1c_reduction: HbA1c reductions of 1.1–1.4% across dose arms versus 0.4% with placebo at 104 weeks. (Secondary)
  • weight_loss: Body-weight reduction of 3.6–6.0 kg versus 1.4 kg placebo depending on dose. (Secondary)
  • cardiovascular: MACE occurred in 6.6% of semaglutide participants versus 8.9% of placebo over 104 weeks (HR 0.74), meeting non-inferiority and superiority criteria. (Primary outcome)

Reported dosage

  • 1 mg Ā· once weekly subcutaneous Ā· 104 weeks — Higher dose arm in SUSTAIN-6.
  • 0.5 mg Ā· once weekly subcutaneous Ā· 104 weeks — Lower dose arm in SUSTAIN-6; after initial 0.25 mg run-in.
DOI: 10.1056/NEJMoa1607141 ↗

Get the full companion experience in Viora

Week-by-week reminders, food and symptom tracking, and the complete companion guide in one place.

Available on iOS and Android.